Skip to main content
SpringerLink
Log in

Placeboeffekte und ihre Implikationen in der Neurologie

Positive Erwartung, Konditionierung, Lernprozess

  • zertifizierte fortbildung
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

Zusammenfassung

Aktuelle neurowissenschaftliche und klinische Befunde zu positiven physiologischen oder psychologischen Veränderungen nach Einnahme von Medikamenten ohne spezifische Wirkstoffe oder Scheineingriffen haben wichtige Implikationen für die praktische Behandlung. Diese „Placeboeffekte“ sind besonders für Patienten mit neurologischen Erkrankungen relevant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2
3

Literatur

  1. Enck P, Bingel U, Schedlowski M, Rief W. The placebo response in medicine: minimize, maximize or personalize? Nature reviews Drug discovery. 2013;12(3):191–204. Epub 2013/03/02.

    Article  CAS  PubMed  Google Scholar 

  2. Klinger R. [The potential of the analgetic placebo effect - s3-guideline recommendation on the clinical use for acute and perioperative pain management]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2010;45(1):22–9. Epub 2010/01/22. Das Potenzial des analgetischen Placeboeffektes - S3-Leitlinien-Empfehlung zur Behandlung akuter und perioperativer Schmerzen. rklinger@uni-hamburg.de.

    Article  PubMed  Google Scholar 

  3. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 1999;19(1):484–94.

    CAS  PubMed  Google Scholar 

  4. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003;23(10):4315–23.

    CAS  PubMed  Google Scholar 

  5. Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S, et al. Behavioral conditioning of immunosuppression is possible in humans. Faseb J. 2002;16(14):1869–73.

    Article  CAS  PubMed  Google Scholar 

  6. Vase L, Riley JL, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain. 2002;99(3):443–52.

    Article  PubMed  Google Scholar 

  7. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344(21):1594–602.

    Article  CAS  PubMed  Google Scholar 

  8. Vase L, Petersen GL, Riley JL, 3rd, Price DD. Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain. 2009;145(1–2):36–44.

    Article  PubMed  Google Scholar 

  9. Krogsboll LT, Hrobjartsson A, Gotzsche PC. Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC medical research methodology. 2009;9:1. Epub 2009/01/07.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Rutherford BR, Mori S, Sneed JR, Pimontel MA, Roose SP. Contribution of spontaneous improvement to placebo response in depression: a meta-analytic review. Journal of psychiatric research. 2012;46(6):697–702. Epub 2012/03/14.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet. 1978;2(8091):654–7.

    Article  CAS  PubMed  Google Scholar 

  12. Eippert F, Finsterbusch J, Bingel U, Buchel C. Direct evidence for spinal cord involvement in placebo analgesia. Science. 2009;326(5951):404.

    Article  CAS  PubMed  Google Scholar 

  13. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009;63(4):533–43.

    Article  CAS  PubMed  Google Scholar 

  14. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci. 2005;25(34):7754–62. Epub 2005/08/27.

    Article  CAS  PubMed  Google Scholar 

  15. Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A. 2007;104(26):11056–61.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nature medicine. 2011;17(10):1228–30. Epub 2011/10/04.

    Article  CAS  PubMed  Google Scholar 

  17. Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K, Ingvar M. Placebo in emotional processing—induced expectations of anxiety relief activate a generalized modulatory network. Neuron. 2005;46(6):957–69. Epub 2005/06/15.

    Article  CAS  PubMed  Google Scholar 

  18. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry. 2002;159(5):728–37.

    Article  PubMed  Google Scholar 

  19. Furmark T, Appel L, Henningsson S, Ahs F, Faria V, Linnman C, et al. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci. 2008;28(49):13066–74.

    Article  CAS  PubMed  Google Scholar 

  20. Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol. 2009;29(4):372–7.

    Article  CAS  PubMed  Google Scholar 

  21. de La Fuente-Fernandez R, Lim AS, Sossi V, Holden JE, Calne DB, Ruth TJ, et al. Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition. J Cereb Blood Flow Metab. 2001;21(10):1151–9.

    Article  Google Scholar 

  22. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci. 2004;7(6):587–8.

    Article  CAS  PubMed  Google Scholar 

  23. Benedetti F, Lanotte M, Colloca L, Ducati A, Zibetti M, Lopiano L. Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response. J Physiol. 2009;587(Pt 15):3869–83.

    Article  CAS  PubMed  Google Scholar 

  24. Schweinhardt P, Seminowicz DA, Jaeger E, Duncan GH, Bushnell MC. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J Neurosci. 2009;29(15):4882–7. Epub 2009/04/17.

    Article  CAS  PubMed  Google Scholar 

  25. Benedetti F, Carlino E, Pollo A. Hidden administration of drugs. Clin Pharmacol Ther. 2011;90(5):651–61.

    Article  CAS  PubMed  Google Scholar 

  26. Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F. Response expectancies in placebo analgesia and their clinical relevance. Pain. 2001;93(1):77–84.

    Article  CAS  PubMed  Google Scholar 

  27. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol. 2004;3(11):679–84.

    Article  PubMed  Google Scholar 

  28. Kirk JM, Doty P, De Wit H. Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 1998;59(2):287–93.

    Article  CAS  PubMed  Google Scholar 

  29. Metrik J, Rohsenow DJ, Monti PM, McGeary J, Cook TA, de Wit H, et al. Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol. 2009;17(4):217–25.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, et al. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci. 2003;23(36):11461–8.

    CAS  PubMed  Google Scholar 

  31. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 2011;3(70):70ra14.

    Article  PubMed  Google Scholar 

  32. Rief W, Nestoriuc Y, Weiss S, Welzel E, Barsky AJ, Hofmann SG. Meta-analysis of the placebo response in antidepressant trials. Journal of affective disorders. 2009;118(1–3):1–8. Epub 2009/02/28.

    Article  CAS  PubMed  Google Scholar 

  33. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Archives of internal medicine. 2006;166(2):155–60. Epub 2006/01/25.

    Article  PubMed  Google Scholar 

  34. Nestoriuc Y, Orav EJ, Liang MH, Horne R, Barsky AJ. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis care & research. 2010;62(6):791–9. Epub 2010/03/02.

    Article  Google Scholar 

  35. Klinger R. The potential of the analgetic placebo effect - s3-guideline recommendation on the clinical use for acute and perioperative pain management. Anasthesiol Intensivmed Notfallmed Schmerzther.45(1):22–9.

  36. Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth. 2009;9(12):39–47.

    Article  PubMed  Google Scholar 

  37. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. Bmj. 2008;336(7651):999–1003.

    Article  PubMed  Google Scholar 

  38. Doering BK, Rief W. Utilizing placebo mechanisms for dose reduction in pharmacotherapy. Trends Pharmacol Sci. 2012;33(3):165–72. Epub 2012/01/31.

    Article  CAS  PubMed  Google Scholar 

  39. Goebel MU, Meykadeh N, Kou W, Schedlowski M, Hengge UR. Behavioral conditioning of antihistamine effects in patients with allergic rhinitis. Psychother Psychosom. 2008;77(4):227–34.

    Article  PubMed  Google Scholar 

  40. Sandler AD, Glesne CE, Bodfish JW. Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder? Journal of developmental and behavioral pediatrics: JDBP. 2010;31(5):369–75. Epub 2010/05/25.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science. 1982;215(4539):1534–6. Epub 1982/03/19.

    Article  CAS  PubMed  Google Scholar 

  42. Schedlowski M, Pacheco-Lopez G. The learned immune response: Pavlov and beyond. Brain, behavior, and immunity. 2010;24(2):176–85. Epub 2009/08/25.

    Article  PubMed  Google Scholar 

  43. Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, et al. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PloS one. 2012;7(10):e48135. Epub 2012/10/31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Stein N, Sprenger C, Scholz J, Wiech K, Bingel U. White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain. 2012;153(11):2210–7. Epub 2012/09/11.

    Article  PubMed  Google Scholar 

  45. Kong J, Jensen K, Loiotile R, Cheetham A, Wey H-Y, Tan Y, et al. Functional connectivity of frontoparietal network predicts cognitive modulation of pain. Pain. 2012;in press.

  46. Hashmi JA, Baria AT, Baliki MN, Huang L, Schnitzer TJ, Apkarian AV. Brain networks predicting placebo analgesia in a clinical trial for chronic back pain. Pain. 2012;153(12):2393–402. Epub 2012/09/19.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I, et al. Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain. 2006;121(1–2):133–44.

    Article  CAS  PubMed  Google Scholar 

  48. Rief W, Bingel U, Schedlowski M, Enck P. Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials. Clin Pharmacol Ther. 2011.

  49. Laferton JA, Shedden Mora M, Auer CJ, Moosdorf R, Rief W. Enhancing the efficacy of heart surgery by optimizing patients’ preoperative expectations: study protocol of a randomized controlled trial. American heart journal. 2013;165(1):1–7. Epub 2012/12/15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Essen, Abteilung für Neurologie, Universität Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Deutschland

    Ulrike Bingel

Authors
  1. Ulrike Bingel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrike Bingel.

Additional information

Interessenkonflikt

Die Autorin erklärt, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließ und dass keine potenziellen Interessenkonflikte vorliegen.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bingel, U. Placeboeffekte und ihre Implikationen in der Neurologie. InFo Neurologie 16, 46–56 (2014). https://doi.org/10.1007/s15005-013-0310-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-013-0310-4

Search

Navigation